正常人与心血管疾病患者心肌肌钙蛋白水平的变异性:分析考量与临床意义
本文讨论高敏方法检测的心脏肌钙蛋白I和T在同一个体内随时间变异的统计与生物学考量,指出循环水平变化不仅取决于方法分析误差,还取决于生物标志物的个体内变异,并探讨其在急性冠脉综合征鉴别诊断、心血管风险评估和化疗心脏毒性评估中的临床意义。
要点
- hs-cTnI和hs-cTnT的变化用于急性心肌损伤检测。
- 变异评估有助于急诊ACS鉴别、围术期风险及化疗心脏毒性评估。
- 循环水平变异取决于分析方法误差和个体内变异。
核心结论
- hs-cTnI和hs-cTnT的循环水平变化应结合方法分析误差和个体内变异进行解读。
研究设计与样本
- 本文为综述性文档,讨论hs-cTnI和hs-cTnT个体内变异的统计与生物学考量。
主要发现
- hs-cTnI和hs-cTnT变异评估对急诊ACS鉴别诊断、心血管风险评估和化疗心脏毒性评估有临床相关性。
临床怎么用
- 对急诊ACS患者、接受心脏或非心脏手术患者、55岁以上有合并症的无症状人群及接受化疗的恶性肿瘤患者,可评估hs-cTnI和hs-cTnT随时间的变化。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
In accordance with all the most recent international guidelines, the variation of circulating levels of cardiac troponins I and T, measured with high-sensitivity methods (hs-cTnI and hs-cTnT), should be used for the detection of acute myocardial injury. Recent experimental and clinical evidences have demonstrated that the evaluation of hs-cTnI and hs-cTnT variations is particularly relevant: a) for the differential diagnosis of Acute Coronary Syndromes (ACS) in patients admitted to the Emergency Department (ED); b) for the evaluation of cardiovascular risk in patients undergoing major cardiac or non-cardiac surgery, and in asymptomatic subjects of the general population aged >55 years and with co-morbidities; c) for the evaluation of cardiotoxicity caused by administration of some chemotherapy drugs in patients with malignant tumors. The aim of this document is to discuss the fundamental statistical and biological considerations on the intraindividual variability of hs-cTnI and hs-cTnT over time in the same individual. Firstly, it will be discussed in detail as the variations of circulating levels strictly depend not only on the analytical error of the method used but also on the intra-individual variability of the biomarker. Afterwards, the pathophysiological interpretation and the clinical relevance of the determination of the variability of the hs-cTnI and hs-cTnT values in patients with specific clinical conditions are discussed. Finally, the evaluation over time of the variation in circulating levels of hs-cTnI and hs-cTnT is proposed for a more accurate estimation of cardiovascular risk in asymptomatic subjects from the general population.
引用
- Clerico A, Zaninotto M, Aimo A, et al. Variability of cardiac troponin levels in normal subjects and in patients with cardiovascular diseases: analytical considerations and clinical relevance. Clin Chem Lab Med. 2023. PMID: 36695506. doi:10.1515/cclm-2022-1285
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。